Roivant Sciences
S&P 400
$40.82
-0.29%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Current assets comfortably cover current liabilities (current ratio 18.37).
!Watch-points
- Return on equity is on the lower side at -7.1%.
- Return on capital employed is on the lower side at -10.3%.
- The company reported a net loss in the latest period.
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreSafe zone
33.27
In Altman’s original study, companies in this range showed a low incidence of financial distress.
Piotroski F-ScoreWeak
0 / 6
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 6 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap$29.49B
Current Price$ 40.82
High / Low$ 42.50 / 13.81
Stock P/E-75.59
Book Value$ 5.87
Dividend Yield0%
ROCE-10.25%
ROE-7.08%
Current Ratio18.37
P/B Ratio6.971819
EPS$ -0.54
PAT Margin-3629.19%
Cash PAT$-296.42M